WE HIT BULLS EYE ON TREASURY BAILOUT PLAN,SELL BCS, WATCH UBS AND RBS FOR SALE, OTHER SHORTS AND ARBITRAGE OPPORTUNITITIES

We hit bulls eye by informing you before it was generally known that the bailouut will not cover non US institutions and providing you with the oppotunity to exit BCS position with over 30% profit in three days. Following is the text of the Treasury plan: September 20, 2008, 1:05

Read More

CONSIDER BUYING BAC (BANK OF AMERICA)

Strategic value of MER outweigh potential loses from MER balance sheet. BAC has traditionally done a good job at integrating acquisitions, but MER is a different animal than traditional commercial bank acquisitions. However, our review shows that more likely than not MER will be successfully integrated in BAC and strategic

Read More

CONSIDER BUYING BCS (BARCLAYS)

We believe BCS purchase of Lehman assets in bankruptcy is a coup. This is a major change as it will significantly increase BCS presence in US. The current financial crises will pass and the assets bought cheap will pay rich dividends. Consider scaling in in $22-23 range and add on

Read More

HOLD SNDK (SANDISK) LONG POSITION

After the close, Samsung announced $26 cash bid for SNDK. The offer is not contingent on financing. We believe there is a distinct possibility of a competing bod from Toshiba. On the other hand there is some antitrust risk in Samsung bid. On balance, we believe it is advantageous to

Read More

CONSIDER PARTIAL SELL SNDK (SANDISK)

Recently, we warned against shorting SNDK and recommended buying SNDK around $13 due to possibility of a buy out. Today Korea’s ETimes reports that Samsung may be considering buying SNDK. Our sources indicate that report is true. Moreover, it makes sense. In keeping with our methodology to lock in profits

Read More

CONSIDER BUYING TO COVER AMLN (AMLYN)

We have very large gains in AMLN. Consider buying to cover majority, say 90% of the position right here at $20.50 range. Tight stop on the rest. If there is a substantial bounce, consider shorting again. www.thearorareport.com THE ARORA REPORT, Ltd. HOME OF THE UNIQUE ZYX CHANGE METHOD DEDICATED SOLELY

Read More

CONSIDER PARTIAL EXIT KG (KING) AND ALO (ALPHARMA)

There are over 5% gains in just one day. Our methodology calls for taking partial profits in KG here at $11.64 and in ALO at $36.40. Consider tight stops on the rest. www.thearorareport.com THE ARORA REPORT, Ltd. HOME OF THE UNIQUE ZYX CHANGE METHOD DEDICATED SOLELY TO PROFIT FROM CHANGE

Read More

SHORT KG ( KING PHARMACEUTICAL ), BUY ALO (ALPHARMA)

KG today made public its $33 cash offer for ALO ( Alpharma ). Normally stock of the acquirer falls, but here KG stock has jumped. The reason for jump is KG representation that the deal will be accretive in the second year. We believe this premise to be false for

Read More

A fortune is to be made from AI stocks.
Get the list of 18 AI stocks to grab your share of the profits — no cost to you.

A fortune is to be made from AI stocks.

Get the list of 18 AI stocks to grab your share of the profits.

AI is a $1 Trillion Market

Making A Fortune
In Artificial Intelligence

Golden Age of Artificial Intelligence

Skip to content